FFA
HUMA icon

Farther Finance Advisors’s Humacyte HUMA Stock Holding History

Farther Finance Advisors’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.22K Buy
1,548
+723
+88% +$670 ﹤0.01% 5315
2026
Q1 		$488 Buy
825
+802
+3,487% +$834 ﹤0.01% 5277
2025
Q4 		$22 Buy
+23
New +$33 ﹤0.01% 5391
2025
Q2 		– Sell
-6,125
Closed -$9.13K – 4569
2025
Q1 		$9.13K Buy
6,125
+5,995
+4,612% +$22.5K ﹤0.01% 2788
2024
Q4 		$657 Buy
+130
New +$643 ﹤0.01% 3377

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Farther Finance Advisors's HUMA Position: Q2 2026 in Review

Farther Finance Advisors increased its Humacyte (HUMA) stake by 88% in Q2 2026, buying an estimated $670 and bringing the position to 1,548 shares worth $1.22K. The position accounts for ﹤0.01% of the portfolio, ranked #5315.

Farther Finance Advisors first reported a position in HUMA in Q4 2024 and has held it in 5 quarters since. The position peaked at $9.13K in Q1 2025. 161 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Farther Finance Advisors held 1,548 shares of Humacyte worth $1.22K as of Q2 2026.
  • Farther Finance Advisors bought 723 Humacyte shares in Q2 2026, an estimated $670.
  • Humacyte made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5315 holding.
  • Farther Finance Advisors first reported a position in Humacyte in Q4 2024 and has held it in 5 quarters since.
  • Farther Finance Advisors's Humacyte position peaked at $9.13K in Q1 2025.
  • 161 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.